The purpose of this
study is to compare lupus (SLE) and rheumatoid arthritis ( RA) VitD serum
values in the geographical region of northeastern Iran. Lupus and RA patients
with varying levels of disease activity were chosen. Similar quantities of VitD
supplementation were obtained by all patients and selected With the same criteria for inclusion and
exclusion. A commercial ELISA kit measured the VitD serum values. SPSS-15
analysed the results. 148 SLE and 156 RA patients were examined in total. In
the SLE group, VitD serum levels were 66.54±41.2 nmol / l, and in the RA group,
83.74±46.45 nmol / l. Statistical research found that serum levels of VitD were
lower than those of RA in lupus patients (p=0.006). Compared to RA, lower VitD
values in lupus patients can stem from intestinal malabsorption, higher doses
of corticosteroid therapy, renal involvement and proteinuria, different VitD
receptor polymorphisms, and more strategies for lupus patients to protect the
sun.
Author (s) Details
Sahebari
Maryam
Rheumatic Diseases Research Center, School of
Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Elham Atabati
Rheumatic
Diseases Research Center, School of Medicine, Mashhad University of Medical
Sciences, Mashhad, Iran. and Cellular and Molecular Research Center, School of
Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Ravanshad Yalda
Clinical
Research Development Unit, Ghaem Hospital, School of Medicine, Mashhad
University of Medical Sciences, Mashhad, Iran.
View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/272
No comments:
Post a Comment